Months before two infants died and another was hospitalized from bacterial infections, a whistleblower alerted senior FDA officials to what he said were "lax practices, including regulatory violations" at an Abbott Nutrition infant formula plant last October. But it was still months before the FDA investigated and formula was recalled. Helena Bottemiller-Evich reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
